How is Abilify Maintenasupplied?

Dosage Forms And Strengths
  • Pre-filled dual chamber syringe with lyophilized powder for intramuscular gluteal injection for extended-release injectable suspension: 300 mg and 400 mg in a single-use pre-filled dual chamber syringe.
  • Vials with lyophilized powder for intramuscular gluteal injection for extended-release injectable suspension: 300 mg and 400 mg in a singleuse vial.
The reconstituted extended-release injectable suspension is a uniform, homogeneous suspension that is opaque and milky-white in color. Storage And Handling Pre-filled Dual Chamber Syringe ABILIFY MAINTENA (aripiprazole) pre-filled dual chamber syringe for extendedrelease injectable suspension in single-use syringes is available in 300 mg or 400 mg strength syringes. The pre-filled dual chamber syringe consists of a front chamber that contains the lyophilized powder of aripiprazole monohydrate and a rear chamber that contains sterile water for injection. The 300 mg kit includes (NDC 59148-045-80)
  • 300 mg single-use pre-filled dual chamber syringe containing ABILIFY MAINTENA (aripiprazole) and Sterile Water for Injection for extendedrelease injectable suspension lyophilized powder
  • One 21 gauge, 1.5 inch (38 mm) hypodermic safety needle with needle protection device for non-obese patients
  • One 21 gauge, 2 inch (50 mm) hypodermic safety needle with needle protection device for obese patients
The 400 mg kit includes (NDC 59148-072-80):
  • 400 mg single-use pre-filled dual chamber syringe containing ABILIFY MAINTENA (aripiprazole) and Sterile Water for Injection for extendedrelease injectable suspension lyophilized powder
  • One 21 gauge, 1.5 inch (38 mm) hypodermic safety needle with needle protection device for non-obese patients
  • One 21 gauge, 2 inch (50 mm) hypodermic safety needle with needle protection device for obese patients
Single-Use Vial ABILIFY MAINTENA (aripiprazole) extended-release injectable suspension in singleuse vials is available in 300 mg or 400 mg strength vials. The 300 mg kit includes (NDC 59148-018-71)
  • 300 mg single-use vial of ABILIFY MAINTENA (aripiprazole) extendedrelease injectable suspension lyophilized powder
  • 5 mL single-use vial of Sterile Water for Injection, USP
  • One 3 mL luer lock syringe with pre-attached 21 gauge, 1.5 inch hypodermic safety needle with needle protection device
  • One 3 mL luer lock disposable syringe with luer lock tip
  • One vial adapter
  • One 21 gauge, 1.5 inch (38 mm) hypodermic safety needle with needle protection device for non-obese patients
  • One 21 gauge, 2 inch (50 mm) hypodermic safety needle with needle protection device for obese patients
The 400 mg kit includes (NDC 59148-019-71)
  • 400 mg single-use vial of ABILIFY MAINTENA (aripiprazole) extended release injectable suspension lyophilized powder
  • 5 mL single use vial of Sterile Water for Injection, USP
  • One 3 mL luer lock syringe with pre-attached 21 gauge, 1.5 inch hypodermic safety needle with needle protection device
  • One 3 mL luer lock disposable syringe with luer lock tip
  • One vial adapter
  • One 21 gauge, 1.5 inch (38 mm) hypodermic safety needle with needle protection device for non-obese patients
  • One 21 gauge, 2 inch (50 mm) hypodermic safety needle with needle protection device for obese patients
Storage Pre-filled Dual Chamber Syringe Store below 30°C [86°F]. Do not freeze. Protect the syringe from light by storing in the original package until time of use. Vial Store at 25 °C (77 °F), excursions permitted between 15 °C and 30 °C (59 °F to 86 °F) [see USP Controlled Room Temperature]. Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan. Revised: 09/2014 Last reviewed on RxList: 12/12/2014
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com